Multisystem Inflammatory Syndrome in Children (MIS-C) is a serious condition that has recently been discovered in children 3-6 weeks following infection by COVID-19. Typically, COVID-19 in children causes mild symptoms like the flu, such as fever, fatigue, cough, and body aches. However, since the pandemic began, there have been reports of a more serious condition called MIS-C occurring in a small percentage of children. MIS-C results after the body’s immune system overreacts to exposure to COVID-19, resulting in inflammation throughout the organ systems of the body. This can lead to a syndrome similar to Toxic Shock Syndrome (TSS) or Kawasaki Disease, another inflammatory disease that primarily affects children.
The CDC reports that there have been approximately 2,060 cases of MIS-C as of February 1, 2021. Of these, 99% (2,039) tested positive for COVID-19 (either by rapid testing or antibody screening) while the remaining 1% reported recently being in contact with someone who had tested positive for COVID-19.